Compare MRTN & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRTN | OPK |
|---|---|---|
| Founded | 1946 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 850.3M | 967.3M |
| IPO Year | 1986 | 1995 |
| Metric | MRTN | OPK |
|---|---|---|
| Price | $13.65 | $1.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $19.00 | $2.28 |
| AVG Volume (30 Days) | 1.1M | ★ 3.4M |
| Earning Date | 01-27-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $883,652,000.00 | $642,067,000.00 |
| Revenue This Year | $2.16 | N/A |
| Revenue Next Year | $7.12 | N/A |
| P/E Ratio | $64.90 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.35 | $1.11 |
| 52 Week High | $15.50 | $2.04 |
| Indicator | MRTN | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 68.39 | 41.22 |
| Support Level | $12.22 | $1.25 |
| Resistance Level | $14.02 | $1.31 |
| Average True Range (ATR) | 0.50 | 0.05 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 81.23 | 7.89 |
Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.